Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I-II cervical cancer.

Yamauchi M, Fukuda T, Wada T, Kawanishi M, Imai K, Hashiguchi Y, Ichimura T, Yasui T, Sumi T.

Mol Clin Oncol. 2014 Jul;2(4):518-524. Epub 2014 May 15.

2.

Detection of high-risk human papillomavirus subtypes in cervical glandular neoplasia by in situ hybridization.

Sheng Z, Minato H, Sasagawa T, Nakada S, Kinoshita E, Kurose N, Nojima T, Makinoda S.

Int J Clin Exp Pathol. 2013 Sep 15;6(10):2168-77. eCollection 2013.

3.

Endocervical glandular neoplasia associated with lobular endocervical glandular hyperplasia is HPV-independent and correlates with carbonic anhydrase-IX expression: a Gynaecological Oncology Group Study.

Liao SY, Rodgers WH, Kauderer J, Darcy KM, Carter R, Susumu N, Nagao S, Walker JL, Hatae M, Stanbridge EJ.

Br J Cancer. 2013 Feb 19;108(3):613-20. doi: 10.1038/bjc.2012.578. Epub 2013 Jan 8.

4.

Primary endometrial squamous cell carcinoma: a case report and review of relevant literature on korean women.

Lee SJ, Choi HJ.

Korean J Pathol. 2012 Aug;46(4):395-8. doi: 10.4132/KoreanJPathol.2012.46.4.395. Epub 2012 Aug 23.

5.
6.

Equivocal p16 immunostaining in squamous cell carcinoma of the head and neck: staining patterns are suggestive of HPV status.

Chen ZW, Weinreb I, Kamel-Reid S, Perez-OrdoƱez B.

Head Neck Pathol. 2012 Dec;6(4):422-9. doi: 10.1007/s12105-012-0382-3. Epub 2012 Jul 17.

7.

Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study.

Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Darcy KM, Carter R, Levine L, Spirtos NM, Susumu N, Fujiwara K, Walker JL, Hatae M, Stanbridge EJ.

Br J Cancer. 2011 Jan 18;104(2):353-60. doi: 10.1038/sj.bjc.6606049. Epub 2010 Dec 14.

8.

p16(INK4a) immunostaining in cytological and histological specimens from the uterine cervix: a systematic review and meta-analysis.

Tsoumpou I, Arbyn M, Kyrgiou M, Wentzensen N, Koliopoulos G, Martin-Hirsch P, Malamou-Mitsi V, Paraskevaidis E.

Cancer Treat Rev. 2009 May;35(3):210-20. doi: 10.1016/j.ctrv.2008.10.005. Epub 2009 Mar 3. Review.

9.

Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia.

Cuschieri K, Wentzensen N.

Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2536-45. doi: 10.1158/1055-9965.EPI-08-0306. Review.

10.

Frozen-section evaluation of cervical adenocarcinoma at time of radical trachelectomy: pathologic pitfalls and the application of an objective scoring system.

Park KJ, Soslow RA, Sonoda Y, Barakat RR, Abu-Rustum NR.

Gynecol Oncol. 2008 Sep;110(3):316-23. doi: 10.1016/j.ygyno.2008.05.029. Epub 2008 Jul 17.

11.

Newer developments in immunohistology.

Leong AS, Leong TY.

J Clin Pathol. 2006 Nov;59(11):1117-26. Review.

12.

Immunocytochemistry of p16INK4a in liquid-based cervicovaginal specimens with modified Papanicolaou counterstaining.

Negri G, Moretto G, Menia E, Vittadello F, Kasal A, Mian C, Egarter-Vigl E.

J Clin Pathol. 2006 Aug;59(8):827-30. Epub 2006 Feb 7.

13.

p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.

Murphy N, Ring M, Heffron CC, King B, Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O, O'Leary JJ.

J Clin Pathol. 2005 May;58(5):525-34.

14.

Protein p16 as a marker of dysplastic and neoplastic alterations in cervical epithelial cells.

Volgareva G, Zavalishina L, Andreeva Y, Frank G, Krutikova E, Golovina D, Bliev A, Spitkovsky D, Ermilova V, Kisseljov F.

BMC Cancer. 2004 Aug 31;4:58.

15.

Chromosome in situ hybridisation, Ki-67, and telomerase immunocytochemistry in liquid based cervical cytology.

Cheung AN, Chiu PM, Tsun KL, Khoo US, Leung BS, Ngan HY.

J Clin Pathol. 2004 Jul;57(7):721-7.

16.

Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma.

Zhao P, Hu YC, Talbot IC.

World J Gastroenterol. 2003 Oct;9(10):2202-6.

Supplemental Content

Support Center